Design of a phase 2, prospective, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of lanreotide depot 120 mg in patients with well differentiated, advanced lung, or thymus neuroendocrine tumors (NETs) Meeting Abstract
| Authors: | Reidy-Lagunes, D.; Wolin, E. M.; Pitman-Lowenthal, S.; Cox, D.; Kulke, M. H. |
| Abstract Title: | Design of a phase 2, prospective, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of lanreotide depot 120 mg in patients with well differentiated, advanced lung, or thymus neuroendocrine tumors (NETs) |
| Meeting Title: | 8th Annual Meeting of the North American NeuroEndocrine Tumor Society (NANETS) |
| Journal Title: | Pancreas |
| Volume: | 45 |
| Issue: | 3 |
| Meeting Dates: | 2015 Oct 14-18 |
| Meeting Location: | Austin, TX |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2016-03-01 |
| Start Page: | 480 |
| End Page: | 481 |
| Language: | English |
| ACCESSION: | WOS:000370956600067 |
| PROVIDER: | wos |
| DOI: | 10.1097/MPA.0000000000000615 |
| Notes: | Meeting Abstract -- Source: Wos |
